812a Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
| Autor: | Feagan, Brian G., Sandborn, William, Panés, Julian, Ferrante, Marc, Louis, Edouard, D'Haens, Geert R., Franchimont, Denis, Kaser, Arthur, Dewit, Olivier, Seidler, Ursula, Kim, Kyung-Jo, Neurath, Markus, Scholl, Paul, Visvanathan, Sudha, Padula, Steven, Herichova, Ivona, Soaita, Adina, Hall, David, Böcher, Wulf O. |
|---|---|
| Zdroj: | Gastroenterology (00165085); Apr2016 Supplement 1, Vol. 150, pS1266-S1266, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|